342 A phase 1/2 study evaluating the safety, pharmacokinetics and efficacy of ABT-414 in subjects with advanced solid tumors likely to over-express the epidermal growth factor receptor (EGFR) - Tolcher, A.; Goss, G.; Gordon, M.; Gandhi, L.; Papadopoulos, K.P.; Rasco, D.; Pedersen, M.; Fischer, J.; Ames, W.; Xiong, H.; Dudley, M.; Munasinghe, W.; et al. (European journal of cancer (1990), 2014)